Skip to main content

Cancer Center members contribute to the mission of the Center via their participation in research, including laboratory, clinical, and population- based efforts. Membership alignment is limited to one program.

Primary Criteria for Membership

  • Active cancer research as a primary professional focus
  • Interest in the application of research to improve cancer care

Learn more about membership types and categories.

HCI Membership Benefits At-a-Glance

Eligibility for: Type 1 Type 2 Type 3
HCI Investigator Designation X X X
CC Leadership

X

   
HCI Translational Scholar

X

   
Strategic Planning X X  
Input on Program, Shared Resource Development X X  
Program Funding X* X*  
CIT Funding X* X*  
CCSG Supplement Funding X* X*  
Shared Resources Access X X X
Clinical Research Support (cancer-focused interventional treatment trials) X X X
Receipt of, or Participation in:
Funding Announcements X X X
HCI Newsletter X X X
Retreats/Symposia, etc. X X X

*Details regarding funding opportunities can be found on the Benefits and Responsibilities page.

Cancer Center Director

Cornelia Ulrich, MS, PhD

HCI Senior Directors

Neeraj Agarwal, MD
Clinical Research Innovation
Donald E. Ayer, PhD
Cancer Training and Career Enhancement
Max Loveless, MBA
Senior Administrative Director
Martin McMahon, PhD
Preclinical Translation
Kolawole S. Okuyemi, MD, MPH
Equity, Diversity, and Inclusion
Tracy Onega, PhD, MS
Population Sciences
Community Outreach and Engagement (Interim)
Aik Choon Tan, PhD
Data Science
Alana Welm, PhD
Basic Science
Theresa Werner, MD
Clinical Research

Program Leadership

Nuclear Control of Cell Growth and Differentiation

Jay Gertz, PhD
Co-Leader
Jared Rutter, PhD
Co-Leader

Cell Response and Regulation

Sheri Holmen, PhD
Co-Leader

Experimental Therapeutics

Howard Colman, MD, PhD
Co-Leader
Martin McMahon, PhD
Co-Leader

Cancer Control and Population Sciences

Jennifer Doherty, MS, PhD
Co-Leader
Kathleen Mooney, PhD
Co-Leader